Evidence map›Paper›PMID 42315098›Full record

ArticleAmerican journal of physiology. Renal physiology2026

A new brake on podocyte injury: ATOH8 meets TGF-β.

Stuart J Shankland, Oliver Wessely

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of physiology. Renal physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Stuart J ShanklandDivision of Nephrology, University of Washington, Seattle, Washington, United States.ORCID 0000-0002-4616-8330
Oliver WesselyDepartment of Heart, Blood and Kidney Research, Cleveland Clinic Research, Cleveland Clinic Foundation, Cleveland, Ohio, United States.ORCID 0000-0001-6440-7975

Funding

Cell specific delivery of novel therapies to enhance glomerular regeneration and repairUC2DK126006 · NIDDK · UNIVERSITY OF WASHINGTON · PI SHANKLAND, STUART JAMES · 2020 to 2024
$4.0M
Autocrine and paracrine podocyte signals decrease glomerular function/health in aged kidneysR01DK128204 · NIDDK · UNIVERSITY OF WASHINGTON · PI Stuart James Shankland, Oliver Wessely · 2022 to 2026
$3.7M
Targeting Podocyte-Endothelial Cell Crosstalk as a FSGS TherapyR01DK135716 · NIDDK · UNIVERSITY OF WASHINGTON · PI Stuart James Shankland, Oliver Wessely · 2023 to 2026
$2.9M
The Intersection of Podocyte Disease and AgingR01AG079935 · NIA · UNIVERSITY OF WASHINGTON · PI Stuart James Shankland, Oliver Wessely · 2023 to 2026
$2.9M
DOD | MHS | Congressionally Directed Medical Research Programs (CDMRP) PR180585/PR180585P1HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 5R01AG079935HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 5R01DK135716HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) UC2DK126006NIA NIH HHS R01 AG079935NIDDK NIH HHS R01 DK128204NIDDK NIH HHS R01 DK135716NIDDK NIH HHS UC2 DK126006
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ATOH8glomeruluspodocytepodocytopathyTGF-β

Identifiers

PMID42315098
PMCPMC13492390

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.